Article info

Download PDFPDF
Randomised controlled trial
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment

Authors

  1. Correspondence to: Dr Ivan Gentile, Section of Infectious Diseases (Ed. 18), University of Naples Federico II, via Pansini, 5 I-80131 Naples, Italy; ivan.gentile{at}unina.it
View Full Text

Citation

Gentile I, Borgia G
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment

Publication history

  • First published July 15, 2014.
Online issue publication 
November 19, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.